| Naslov: | Detection of serum and tissue levels of interleukin 39 in psoriasis : a case control study |
|---|
| Avtorji: | ID Hassan, Mohammed (Avtor)
ID Abd El-Raheem, Talal A. (Avtor)
ID Shake, Olfat G. (Avtor)
ID Kamal, Hagar Ali (Avtor)
ID Yaseen, Sara M. (Avtor)
ID Soliman, Amira E. (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://acta-apa.mf.uni-lj.si/journals/acta-dermatovenerol-apa/papers/10.15570/actaapa.2025.13/actaapa.2025.13.pdf
 PDF - Predstavitvena datoteka, prenos (710,20 KB)
MD5: 0000C1AE19F1F4ECB81BDFD644D17CD5
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  ZSD - Združenje slovenskih dermatovenerologov
|
|---|
| Povzetek: | Introduction: Psoriasis is a chronic immune-mediated disorder with a genetic component that primarily affects the skin and has potential systemic involvement. Advances in understanding the interaction between the innate and adaptive immune systems have facilitated improved disease management. Methods: This study included 25 patients with psoriasis and 20 healthy controls of both sexes. All participants underwent detailed medical history-taking and dermatological examination, including assessment of the body surface area and the Psoriasis Area and Severity Index (PASI). Blood samples (3 ml) were collected from all subjects, and 4 mm lesional skin punch biopsies were obtained from psoriatic patients and healthy controls. Results: Serum and tissue levels of interleukin 39 (IL-39) were significantly elevated in psoriatic patients compared to healthy individuals. Patients with a positive family history of psoriasis showed higher serum IL-39 levels than those without such a history. In addition, psoriatic individuals with diabetes mellitus or hypertension had higher serum IL-39 levels than those without these comorbidities. A statistically significant correlation was found between disease severity and serum IL-39 concentration. Conclusions: Elevated serum and tissue IL-39 levels in psoriatic patients suggest a potential role for IL-39 in the pathogenesis of psoriasis, highlighting its possible utility as a biomarker or therapeutic target. |
|---|
| Ključne besede: | psoriasis, cytokines, autoimmune disease, IL-39, ELISA |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.06.2025 |
|---|
| Leto izida: | 2025 |
|---|
| Št. strani: | str. 45-49 |
|---|
| Številčenje: | Vol. 34, issue 2 |
|---|
| PID: | 20.500.12556/DiRROS-29905  |
|---|
| UDK: | 616.5:579 |
|---|
| ISSN pri članku: | 1318-4458 |
|---|
| DOI: | 10.15570/actaapa.2025.13 |
|---|
| COBISS.SI-ID: | 260272387 |
|---|
| Datum objave v DiRROS: | 15.06.2026 |
|---|
| Število ogledov: | 48 |
|---|
| Število prenosov: | 26 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
